But Arthur Caplan, a bioethicist at New York University’s Langone Medical Center, said “the only reason anybody wants to talk to you from a financial company is for insider information.” And Jean-Luc Vachiery, who tests experimental therapies for a rare condition called pulmonary arterial hypertension at the Free University of Brussels, added that hedge-fund managers use sophisticated techniques to try to glean confidential information, carefully dissecting verbal answers and body language.
via Researchers Risk Insider Trading — The Scientist Magazine
